Antithrombin III Levels and Outcomes Among Patients With Trauma
Sign Up to like & getrecommendations! Published in 2024 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2024.27786
Abstract: Key Points Question Is antithrombin III deficiency associated with thrombohemorrhagic complications among patients with trauma? Findings In this cohort study of 292 patients with trauma, antithrombin III deficiency was associated with fewer ventilator-free days, hospital-free… read more here.
Keywords: trauma antithrombin; among patients; antithrombin iii; iii levels ... See more keywords
#477 The role of antithrombin III deficiency in hypercoagulability of nephrotic syndrome: insights from a cross-sectional study
Sign Up to like & getrecommendations! Published in 2025 at "Nephrology Dialysis Transplantation"
DOI: 10.1093/ndt/gfaf116.1111
Abstract: Nephrotic syndrome (NS), a clinical manifestation of glomerular diseases, is defined by significant proteinuria (>3.5 g/day), hypoalbuminemia, edema, and hyperlipidemia. Patients with NS are at a heightened risk of thromboembolic events, with incidence rates ranging… read more here.
Keywords: study; pathology; iii deficiency; deficiency ... See more keywords
Effect of fenofibrate on plasma apolipoprotein C-III levels: a systematic review and meta-analysis of randomised placebo-controlled trials
Sign Up to like & getrecommendations! Published in 2018 at "BMJ Open"
DOI: 10.1136/bmjopen-2018-021508
Abstract: Objectives This meta-analysis of randomised placebo-controlled clinical trials aimed to assess the effect of fenofibrate on apolipoprotein C-III (apo C-III), a key regulator of triglyceride metabolism. Materials and methods Randomised placebo-controlled trials investigating the impact… read more here.
Keywords: iii; placebo controlled; analysis; randomised placebo ... See more keywords
Plasma Antithrombin III Levels Can Be a Prognostic Factor in Liver Cirrhosis Patients with Portal Vein Thrombosis
Sign Up to like & getrecommendations! Published in 2023 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms24097732
Abstract: Liver function influences the plasma antithrombin (AT)-III levels. AT-III is beneficial for patients with portal vein thrombosis (PVT) and low plasma AT-III levels. However, whether these levels affect prognosis in patients with cirrhosis-associated PVT remains… read more here.
Keywords: plasma antithrombin; low plasma; iii levels; iii ... See more keywords